Consun Pharmaceutical Group Limited (1681.HK)
HKD 9.7
(-0.41%)
HKD 9.7
(-0.41%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 367.08 Million CNY | 27.61% |
| 2022 | 287.66 Million CNY | 11.66% |
| 2021 | 257.61 Million CNY | 13.3% |
| 2020 | 227.37 Million CNY | 7.92% |
| 2019 | 210.68 Million CNY | 0.18% |
| 2018 | 210.31 Million CNY | 5.15% |
| 2017 | 200 Million CNY | 41.87% |
| 2016 | 140.97 Million CNY | 98.52% |
| 2015 | 71.01 Million CNY | 32.78% |
| 2014 | 53.48 Million CNY | 9.22% |
| 2013 | 48.96 Million CNY | 118.19% |
| 2012 | 22.44 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 364.32 Million CNY | 0.0% |
| 2023 Q2 | 343.46 Million CNY | 0.0% |
| 2023 Q4 | 367.08 Million CNY | 0.0% |
| 2023 FY | 367.08 Million CNY | 27.61% |
| 2022 FY | 287.66 Million CNY | 11.66% |
| 2022 Q4 | 287.66 Million CNY | 0.0% |
| 2022 Q2 | 257.74 Million CNY | 0.0% |
| 2021 Q4 | 257.61 Million CNY | 0.0% |
| 2021 FY | 257.61 Million CNY | 13.3% |
| 2021 Q2 | 240.2 Million CNY | 0.0% |
| 2020 Q4 | 227.37 Million CNY | 0.0% |
| 2020 Q2 | 192.15 Million CNY | 0.0% |
| 2020 FY | 227.37 Million CNY | 7.92% |
| 2019 FY | 210.68 Million CNY | 0.18% |
| 2019 Q2 | 190.1 Million CNY | 0.0% |
| 2019 Q4 | 210.68 Million CNY | 0.0% |
| 2018 Q4 | 210.31 Million CNY | 0.0% |
| 2018 FY | 210.31 Million CNY | 5.15% |
| 2018 Q2 | 176.94 Million CNY | 0.0% |
| 2017 FY | 200 Million CNY | 41.87% |
| 2017 Q2 | 222.12 Million CNY | 0.0% |
| 2017 Q4 | 200 Million CNY | 0.0% |
| 2016 Q4 | 140.97 Million CNY | 0.0% |
| 2016 FY | 140.97 Million CNY | 98.52% |
| 2016 Q2 | 48.21 Million CNY | 0.0% |
| 2015 Q2 | 56.14 Million CNY | 0.0% |
| 2015 Q4 | 71.01 Million CNY | 0.0% |
| 2015 FY | 71.01 Million CNY | 32.78% |
| 2014 Q2 | 42.26 Million CNY | 0.0% |
| 2014 FY | 53.48 Million CNY | 9.22% |
| 2014 Q4 | 53.48 Million CNY | 0.0% |
| 2013 Q4 | 48.96 Million CNY | 0.0% |
| 2013 Q2 | 30.76 Million CNY | 0.0% |
| 2013 FY | 48.96 Million CNY | 118.19% |
| 2012 FY | 22.44 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -2909.65% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 73.565% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -4952.815% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -19.146% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 14.984% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -23.14% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -484.329% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -273.565% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -109.051% |
| SSY Group Limited | 1.08 Billion HKD | 66.207% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -300.816% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -15.488% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 98.954% |